// App-Quantinova.ai

TCT-413 : Different Safety Pattern of Ticagrelor Monotherapy Following Percutaneous Coronary Interventions Related to Pulse Pressure Levels: A Subanalysis of the GLOBAL LEADERS Randomized Multicenter Trial

Researchers

Presenter

  • Ana Paula de Faria

Principal Investigators

  • Rodrigo Modolo

  • Ply Chichareon

  • Chun-Chin Chang

  • Norihiro Kogame

  • Mariusz Tomaniak

  • Joanna Wykrzykowska

  • Robert de Winter

  • Christian Hamm

  • Peter Juni

  • Pascal Vranckx

  • Marco Valgimigli

  • Stephan Windecker

  • Yoshinobu Onuma

  • Patrick Serruys

Medical Centers

  • Thorax Centre, Erasmus MC, Department of Interventional Cardiology, Rotterdam, Netherlands

  • Swiss Cardiovascular Center, Inselpsital, Bern, Switzerland

  • Academisch Medisch Centrum, Amsterdam, Netherlands

  • Kerckhoff Clinic, Bad Nauheim, Germany

  • Imperial College, London, United Kingdom

  • Medical University of Warsaw, 1st Department of Cardiology, Warsaw, Poland

  • Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland

  • Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands

  • University of Campinas, Campinas, BRA

  • Hartcentre Hasselt, Hasselt, Belgium

  • University of Toronto, TORONTO, Ontario, Canada.

Locations

  • Netherlands

  • United Kingdom

  • Switzerland

  • Germany

  • Canada

  • Poland

  • Belgium

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

Biomarkers

  • N/A

Drug/Treatment

  • Ticagrelor

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • Randomized

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved